Robbins LLP logo white Background.png
IBRX Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in the ImmunityBio, Inc. Class Action
09 août 2023 15h07 HE | Robbins LLP
SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
ImmunityBio investors:Please contact the Portnoy Law Firm to recover your losses; August 29, 2023 deadline
24 juil. 2023 17h49 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, July 24, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ImmunityBio, Inc....
Robbins LLP logo white Background.png
IBRX Stock News: Contact Robbins LLP for Information Regarding ImmunityBio, Inc. Class Action
18 juil. 2023 18h31 HE | Robbins LLP
SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
Robbins LLP logo white Background.png
ImmunityBio, Inc. (IBRX) Investor Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in ImmunityBio, Inc. Class Action
13 juil. 2023 17h40 HE | Robbins LLP
SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
Robbins LLP logo white Background.png
ImmunityBio, Inc. (IBRX) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against ImmunityBio, Inc.
05 juil. 2023 12h19 HE | Robbins LLP
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
PRimage.jpg
IMMUNITYBIO: Kaplan Fox Investigates ImmunityBio
11 mai 2023 19h56 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ImmunityBio, Inc. (“ImmunityBio” or the “Company”)...